We are live on
!
Find out more
EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$201M
1-Year Est. Return
21.29%
This Fund
S&P 500
This Quarter
Est. Return
+2.34%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$141M
AUM Growth
–
Cap. Flow
+$142M
Cap. Flow
% of AUM
100.24%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
111
New
111
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$2.47M |
| 2 |
Colgate-Palmolive
CL
|
+$2.21M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.21M |
| 4 |
PepsiCo
PEP
|
+$2.2M |
| 5 |
RTX Corp
RTX
|
+$2.18M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.43% |
| 2 | Consumer Staples | 15.19% |
| 3 | Technology | 14.65% |
| 4 | Industrials | 14.14% |
| 5 | Consumer Discretionary | 8.43% |
Similar funds
LI
FFL
SWIA
FCM
FIA
SA
FFC
RM
Eads & Heald Wealth Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Eads & Heald Wealth Management, which disclosed 111 positions worth $141M. Its ten largest holdings account for 16% of the portfolio.
Its largest position is Thermo Fisher Scientific: 29,723 shares worth $2.52M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, followed by Consumer Staples and Technology.
- Eads & Heald Wealth Management's largest Q2 2013 buy was Thermo Fisher Scientific: 29,723 shares worth $2.52M.
- Eads & Heald Wealth Management's ten largest holdings make up 16% of its $141M portfolio in Q2 2013.
- Eads & Heald Wealth Management disclosed 111 positions in Q2 2013, its first 13F filing on record.
Based on Eads & Heald Wealth Management's 13F filing for Q2 2013, filed 31 Jul 2013.